Imperial College London
Portrait Picture

Professor Shoumitro (Shoumi) Deb

Faculty of Medicine, Department of Brain Sciences

Visiting Professor
 
 
 
//

Contact

 

+44 (0)20 3313 4161s.deb CV

 
 
//

Location

 

Commonwealth BuildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Deb:2020:10.1192/bjo.2020.97,
author = {Deb, S and Nancarrow, T and Limbu, B and Sheehan, R and Wilcock, M and Branford, D and Courtenay, K and Perera, B and Shankar, R},
doi = {10.1192/bjo.2020.97},
journal = {BJPsych Open},
pages = {1--7},
title = {UK psychiatrists' experience of withdrawal of antipsychotics prescribed for challenging behaviours in adults with intellectual disabilities and/or autism},
url = {http://dx.doi.org/10.1192/bjo.2020.97},
volume = {6},
year = {2020}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - BackgroundA high proportion of adults with intellectual disabilities are prescribed off-licence antipsychotics in the absence of a psychiatric illness. The National Health Service in England launched an initiative in 2016, ‘Stopping over-medication of people with a learning disability [intellectual disability], autism or both’ (STOMP), to address this major public health concern.AimsTo gain understanding from UK psychiatrists working with adults with intellectual disabilities on the successes and challenges of withdrawing antipsychotics for challenging behaviours.MethodAn online questionnaire was sent to all UK psychiatrists working in the field of intellectual disability (estimated 225).ResultsHalf of the 88 respondents stated that they started withdrawing antipsychotics over 5 years ago and 52.3% stated that they are less likely to initiate an antipsychotic since the launch of STOMP. However, since then, 46.6% are prescribing other classes of psychotropic medication instead of antipsychotics for challenging behaviours, most frequently the antidepressants. Complete antipsychotic discontinuation in over 50% of patients treated with antipsychotics was achieved by only 4.5% of respondents (n = 4); 11.4% reported deterioration in challenging behaviours in over 50% of patients on withdrawal and the same proportion (11.4%) reported no deterioration. Only 32% of respondents made the diagnosis of psychiatric illness in all their patients themselves. Family and paid carers’ concern, lack of multi-agency and multidisciplinary input and unavailability of non-medical psychosocial intervention are key reported factors hampering the withdrawal attempt.ConclusionsThere is an urgent need to develop national guidelines to provide a framework for systematic psychotropic drug reviews and withdrawal where possible.
AU  - Deb,S
AU  - Nancarrow,T
AU  - Limbu,B
AU  - Sheehan,R
AU  - Wilcock,M
AU  - Branford,D
AU  - Courtenay,K
AU  - Perera,B
AU  - Shankar,R
DO  - 10.1192/bjo.2020.97
EP  - 7
PY  - 2020///
SN  - 2056-4724
SP  - 1
TI  - UK psychiatrists' experience of withdrawal of antipsychotics prescribed for challenging behaviours in adults with intellectual disabilities and/or autism
T2  - BJPsych Open
UR  - http://dx.doi.org/10.1192/bjo.2020.97
UR  - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000570177800001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
UR  - https://www.cambridge.org/core/journals/bjpsych-open/article/uk-psychiatrists-experience-of-withdrawal-of-antipsychotics-prescribed-for-challenging-behaviours-in-adults-with-intellectual-disabilities-andor-autism/F4E214967F11BA80F24A518BA01D9B65
UR  - http://hdl.handle.net/10044/1/94254
VL  - 6
ER  -
Download